• 1
    Bikfalvi, A., Klein, S., Pintucci, G. & Rifkin, D.B. (1997) Biological roles of fibroblast growth factor-2. Endocr. Rev. 18, 2645.
  • 2
    Risau, W. (1997) Mechanisms of angiogenesis. Nature 386, 671674.
  • 3
    O'Reilly, M.S., Holmgren, L., Shing, Y., Chen, C., Rosenthal, R.A., Moses, M., Lane, W.S., Cao, Y., Sage, E.H. & Folkman, J. (1994) Angiostatin: a novel angiogenesis inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell 79, 315328.
  • 4
    O'Reilly, M.S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W.S., Flynn, E., Birkhead, J., Olsen, B. & Folkman, J. (1997) Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88, 277285.
  • 5
    Taraboletti, G., Roberts, D., Liotta, L.A. & Giavazzi, R. (1990) Platelet thrombospondin modulates endothelial cell adhesion, motility, and growth: a potential angiogenesis regulatory factor. J. Cell Biol. 111, 765772.
  • 6
    Sharpe, R.J., Byers, H.R., Scott, C.F., Bauer, S.I. & Maione, T.E. (1990) Growth inhibition of murine melanoma and human colon carcinoma by recombinant human platelet factor 4. J. Natl Cancer. 82, 848853.
  • 7
    Folkman, J. (1995) Angiogenesis in cancer, vascular, rheumatoid and other disease. Nat. Med. 1, 2731.
  • 8
    Hagedorn, M. & Bikfalvi, A. (2000) Target molecules for anti-angiogenic therapy: from basic research to clinical trials. Crit. Rev. Oncol. Hematol. 34, 89110.
  • 9
    Strieter, R.M., Polverini, P.J., Kunkel, S.L., Arenberg, D.A., Burdick, M.D., Kasper, J., Dzuiba, J., Van Damme, J., Walz, A., Marriott, D., Chan, S.Y., Roczniak, S. & Shanafelt, A.B. (1995) The functional role of the ELR motif in CXC chemokine-mediated angiogenesis. J. Biol. Chem. 270, 2734827357.
  • 10
    Sato, Y., Abe, M. & Takaki, R. (1990) Platelet factor 4 blocks the binding of basic fibroblast growth factor to the receptor and inhibits the spontaneous migration of vascular endothelial cells. Biochem. Biophys. Res. 172, 595600.
  • 11
    Sato, Y., Waki, M., Ohno, M., Kuwano, M. & Sakata, T. (1993) Carboxyl-terminal heparin-binding fragments of platelet factor 4 retain the blocking effect on the receptor binding of basic fibroblast growth factor. Jpn J. Cancer Res. 84, 485488.
  • 12
    Gupta, S.K. & Singh, J.P. (1994) Inhibition of endothelial cell proliferation by platelet factor-4 involves a unique action on S phase progression. J. Cell Biol. 124, 11211127.
  • 13
    Perollet, C., Han, Z.C., Savona, C., Caen, J.P. & Bikfalvi, A. (1998) Platelet factor 4 modulates fibroblast growth factor 2 (FGF-2) activity and inhibits FGF-2 dimerization. Blood 91, 32893299.
  • 14
    Gentilini, G., Kirschbaum, N.E., Augustine, J.A., Aster, R.H. & Visentin, G.P. (1999) Inhibition of human umbilical vein endothelial cell proliferation by the CXC chemokine, platelet factor 4 (PF4), is associated with impaired p21Cip1/WAF1 downregulation. Blood 93, 2533.
  • 15
    Jouan, V., Canron, X., Alemany, M., Caen, J.P., Quentin, G., Plouet, J. & Bikfalvi, A. (1999) Inhibition of in vitro angiogenesis by platelet factor-4-derived peptides and mechanism of action. Blood 94, 984993.
  • 16
    Maione, T.E., Gray, G., Hunt, P. & Sharpe, J. (1991) Inhibition of tumor growth in mice by an analogue of platelet factor 4 that lacks affinity for heparin and retains potent angiostatic activity. Cancer Res. 51, 20772083.
  • 17
    Sulpice, E., Bryckaert, M., Lacour, J., Contreres, J.O. & Tobelem, G. (2002) Platelet factor 4 inhibits FGF2-induced endothelial cell proliferation via the extracellular signal-regulated kinase pathway but not by the phosphatidylinositol 3-kinase pathway. Blood 100, 30873094.
  • 18
    Ferrara, N. (2000) VEGF: an update on biological and therapeutic aspects. Curr. Opin. Biotechnol. 11, 617624.
  • 19
    Ferrara, N. & Davis-Smyth, T. (1997) The biology of vascular endothelial growth factor. Endocr. Rev. 18, 425.
  • 20
    Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M. & Heldin, C.H. (1994) Different signal transduction properties of KDR and Flt1, two receptors for vascular endothelial growth factor. J. Biol. Chem. 269, 2698826995.
  • 21
    Hiratsuka, S., Minowa, O., Kuno, J., Noda, T. & Shibuya, M. (1998) Flt-1 lacking the tyrosine kinase domain is sufficient for normal development and angiogenesis in mice. Proc. Natl Acad. Sci. USA 95, 93499354.
  • 22
    Houck, K.A., Ferrara, N., Winer, J., Cachianes, G., Li, B. & Leung, D.W. (1991) The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol. Endocrinol. 5, 18061814.
  • 23
    Tischer, E., Mitchell, R., Hartman, T., Silva, M., Gospodarowicz, D., Fiddes, J.C. & Abraham, J.A. (1991) The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J. Biol. Chem. 266, 1194711954.
  • 24
    Neufeld, G., Cohen, T., Gitay-Goren, H., Poltorak, Z., Tessler, S., Sharon, R., Gengrinovitch, S. & Levi, B.Z. (1996) Similarities and differences between the vascular endothelial growth factor (VEGF) splice variants. Cancer Metastasis Rev. 15, 153158.
  • 25
    Park, J.E., Keller, G.A. & Ferrara, N. (1993) The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell 4, 13171326.
  • 26
    Gengrinovitch, S., Greenberg, S.M., Cohen, T., Gitay-Goren, H., Rockwell, P., Maione, T., Levi, B.Z. & Neufeld, G. (1995) Platelet factor-4 inhibits the mitogenic activity of VEGF121 and VEGF165 using several concurrent mechanisms. J. Biol. Chem. 270, 1505915065.
  • 27
    Dougher-Vermazen, M., Hulmes, J.D., Bohlen, P. & Terman, B.I. (1994) Biological activity and phosphorylation sites of the bacterially expressed cytosolic domain of the KDR VEGF-receptor. Biochem. Biophys. Res. Commun. 205, 728738.
  • 28
    Xia, P., Aiello, L.P., Ishii, H., Jiang, Z.Y., Park, D.J., Robinson, G.S., Takagi, H., Newsome, W.P., Jirousek, M.R. & King, G.L. (1996) Characterization of vascular endothelial growth factor's effect on the activation of protein kinase C, its isoforms, and endothelial cell growth. J. Clin. Invest. 98, 20182026.
  • 29
    Takahashi, T., Ueno, H. & Shibuya, M. (1999) VEGF activates protein kinase C-dependent, but Ras-independent Raf-MEK-MAP kinase pathway for DNA synthesis in primary endothelial cells. Oncogene 18, 22212230.
  • 30
    Doanes, A.M., Hegland, D.D., Sethi, R., Kovesdi, I., Bruder, J.T. & Finkel, T. (1999) VEGF stimulates MAPK through a pathway that is unique for receptor tyrosine kinases. Biochem. Biophys. Res. 255, 545548.
  • 31
    Wu, L.W., Mayo, L.D., Dunbar, J.D., Kessler, K.M., Baerwald, M.R., Jaffe, E.A., Wang, D., Warren, R.S. & Donner, D.B. (2000) Utilization of distinct signaling pathways by receptors for vascular endothelial cell growth factor and other mitogens in the induction of endothelial cell proliferation. J. Biol. Chem. 275, 50965103.
  • 32
    Kroll, J. & Waltenberger, J. (1997) The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J. Biol. Chem. 272, 3252132527.
  • 33
    Thakker, G.D., Hajjar, D.P., Muller, W.A. & Rosengart, T.K. (1999) The role of phosphatidylinositol 3-kinase in vascular endothelial growth factor signaling. J. Biol. Chem. 274, 1000210007.
  • 34
    Lasagni, L., Francalanci, M., Annunziato, F., Lazzeri, E., Giannini, S., Cosmi, L., Sagrinati, C., Mazzinghi, B., Orlando, C., Maggi, E., Marra, F., Romagnani, S., Serio, M. & Romagnani, P. (2003) An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4. J. Exp. Med. 197, 15371549.
  • 35
    Wellner, M., Maasch, C., Kupprion, C., Lindschau, C., Luft, F.C. & Haller, H. (1999) The proliferative effect of vascular endothelial growth factor requires protein kinase C-alpha and protein kinase C-zeta. Arterioscler. Thromb. Vasc. Biol. 19, 178185.
  • 36
    Mohammadi, M., Dionne, C.A., Li, W., Li, N., Spivak, T., Honegger, A.M., Jaye, M. & Schlessinger, J. (1992) Point mutation in FGF receptor eliminates phosphatidylinositol hydrolysis without affecting mitogenesis. Nature 358, 681684.
  • 37
    Spivak-Kroizman, T., Mohammadi, M., Hu, P., Jaye, M., Schlessinger, J. & Lax, I. (1994) Point mutation in the fibroblast growth factor receptor eliminates phosphatidylinositol hydrolysis without affecting neuronal differentiation of PC12 cells. J. Biol. Chem. 269, 1441914423.
  • 38
    Muslin, A.J., Peters, K.G. & Williams, L.T. (1994) Direct activation of phospholipase C-gamma by fibroblast growth factor receptor is not required for mesoderm induction in Xenopus animal caps. Mol. Cell. Biol. 14, 30063012.
  • 39
    Mason, C.S., Springer, C.J., Cooper, R.G., Superti-Furga, G., Marshall, C.J. & Marais, R. (1999) Serine and tyrosine phosphorylations cooperate in Raf-1, but not B-Raf activation. EMBO J. 18, 21372148.
  • 40
    Wu, J., Dent, P., Jelinek, T., Wolfman, A., Weber, M.J. & Sturgill, T.W. (1993) Inhibition of the EGF-activated MAP kinase signaling pathway by adenosine 3′,5′-monophosphate. Science 262, 10651069.
  • 41
    Dhillon, A.S., Pollock, C., Steen, H., Shaw, P.E., Mischak, H. & Kolch, W. (2002) Cyclic AMP-dependent kinase regulates Raf-1 kinase mainly by phosphorylation of serine 259. Mol. Cell. Biol. 22, 32373246.
  • 42
    Dhillon, A.S., Meikle, S., Yazici, Z., Eulitz, M. & Kolch, W. (2002) Regulation of Raf-1 activation and signalling by dephosphorylation. EMBO J. 21, 6471.
  • 43
    Mischak, H., Seitz, T., Janosch, P., Eulitz, M., Steen, H., Schellerer, M., Philipp, A. & Kolch, W. (1996) Negative regulation of Raf-1 by phosphorylation of serine 621. Mol. Cell. Biol. 16, 54095418.
  • 44
    D'Angelo, G., Lee, H. & Weiner, R.I. (1997) cAMP-dependent protein kinase inhibits the mitogenic action of vascular endothelial growth factor and fibroblast growth factor in capillary endothelial cells by blocking Raf activation. J. Cell Biochem. 67, 353366.
  • 45
    Hafner, S., Adler, H.S., Mischak, H., Janosch, P., Heidecker, G., Wolfman, A., Pippig, S., Lohse, M., Ueffing, M. & Kolch, W. (1994) Mechanism of inhibition of Raf-1 by protein kinase A. Mol. Cell. Biol. 14, 66966703.
  • 46
    Bornfeldt, K.E. & Krebs, E.G. (1999) Crosstalk between protein kinase A and growth factor receptor signaling pathways in arterial smooth muscle. Cell Signal. 11, 465477.
  • 47
    Houslay, M.D. & Kolch, W. (2000) Cell-type specific integration of cross-talk between extracellular signal-regulated kinase and cAMP signaling. Mol. Pharmacol. 58, 659668.
  • 48
    Premack, B.A. & Schall, T.J. (1996) Chemokine receptors: gateways to inflammation and infection. Nat Med. 2, 11741178.
  • 49
    Rollins, B.J. (1997) Chemokines. Blood 90, 909928.
  • 50
    Kunkel, S.L. (1999) Through the looking glass: the diverse in vivo activities of chemokines. J. Clin. Invest. 104, 13331334.